1.92
前日終値:
$1.94
開ける:
$1.97
24時間の取引高:
593.76K
Relative Volume:
0.92
時価総額:
$62.71M
収益:
$832.00K
当期純損益:
$-135.12M
株価収益率:
-0.3153
EPS:
-6.09
ネットキャッシュフロー:
$-124.69M
1週間 パフォーマンス:
+12.28%
1か月 パフォーマンス:
+19.25%
6か月 パフォーマンス:
-61.21%
1年 パフォーマンス:
-83.10%
Inovio Pharmaceuticals Inc Stock (INO) Company Profile
名前
Inovio Pharmaceuticals Inc
セクター
電話
(858) 410-3134
住所
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
INO を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
INO
Inovio Pharmaceuticals Inc
|
1.92 | 62.71M | 832.00K | -135.12M | -124.69M | -6.09 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
432.00 | 115.57B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
574.16 | 60.30B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ARGX
Argen X Se Adr
|
542.47 | 37.56B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
266.86 | 35.18B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ONC
Beigene Ltd Adr
|
224.73 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-05-14 | 開始されました | Stephens | Overweight |
2024-01-25 | アップグレード | Oppenheimer | Perform → Outperform |
2022-11-09 | ダウングレード | Maxim Group | Buy → Hold |
2022-11-01 | ダウングレード | BofA Securities | Neutral → Underperform |
2022-07-19 | 再開されました | RBC Capital Mkts | Sector Perform |
2022-05-11 | ダウングレード | Oppenheimer | Outperform → Perform |
2022-01-21 | アップグレード | BofA Securities | Underperform → Neutral |
2021-12-29 | 再開されました | Jefferies | Hold |
2021-09-10 | ダウングレード | BofA Securities | Neutral → Underperform |
2021-06-24 | 開始されました | Jefferies | Hold |
2021-03-23 | 開始されました | BofA Securities | Neutral |
2021-02-12 | 開始されました | Oppenheimer | Outperform |
2020-11-17 | ダウングレード | ROTH Capital | Neutral → Sell |
2020-11-10 | アップグレード | ROTH Capital | Sell → Neutral |
2020-09-28 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
2020-09-28 | アップグレード | Maxim Group | Hold → Buy |
2020-07-01 | ダウングレード | Maxim Group | Buy → Hold |
2020-07-01 | ダウングレード | ROTH Capital | Neutral → Sell |
2020-06-29 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2020-06-26 | ダウングレード | Stifel | Buy → Hold |
2020-05-21 | 開始されました | The Benchmark Company | Buy |
2020-04-30 | ダウングレード | ROTH Capital | Buy → Neutral |
2020-03-13 | ダウングレード | Piper Sandler | Overweight → Neutral |
2020-03-13 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
2019-12-19 | 開始されました | ROTH Capital | Buy |
2018-02-15 | 繰り返されました | Maxim Group | Buy |
2017-10-18 | 開始されました | RBC Capital Mkts | Outperform |
2017-09-06 | 開始されました | Citigroup | Buy |
2017-06-08 | アップグレード | Piper Jaffray | Neutral → Overweight |
2017-05-24 | 繰り返されました | Maxim Group | Buy |
2017-03-16 | アップグレード | Maxim Group | Hold → Buy |
2017-03-16 | ダウングレード | Piper Jaffray | Overweight → Neutral |
すべてを表示
Inovio Pharmaceuticals Inc (INO) 最新ニュース
Inovio Pharmaceuticals Inc (INO) Q1 2025 Earnings Call Highlights: Strategic Cost Management ... - Yahoo Finance
Inovio Pharmaceuticals (INO) Advances BLA Submission for INO-310 - GuruFocus
Earnings call transcript: Inovio’s Q1 2025 sees narrowed losses, stock rises - Investing.com
Inovio Pharmaceuticals (INO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Inovio: Q1 Earnings Snapshot - San Francisco Chronicle
INO Reports Strong Q1 Revenue, Progress on INO-3107 Submission | - GuruFocus
INOVIO Reports First Quarter 2025 Financial Results and Recent B - GuruFocus
Inovio Pharmaceuticals Inc (INO) Q1 2025 Earnings: EPS of -$0.51 - GuruFocus
Inovio Pharmaceuticals Q1 Operating Expenses USD 25.1 Million - marketscreener.com
INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights - PR Newswire
Inovio Pharmaceuticals (NASDAQ:INO) Lowered to “Sell” Rating by StockNews.com - Defense World
Inovio Pharmaceuticals (INO) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Inovio at The Citizens JMP Life Sciences Conference: DNA Platform Progress - Investing.com Australia
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Shares Sold by Renaissance Technologies LLC - Defense World
Inovio Pharmaceuticals (NASDAQ:INO) Cut to Sell at StockNews.com - Defense World
INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025 - Kilgore News Herald
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
INOVIO to Announce Q1 2025 Results and Host Live Webcast on May 13 - MyChesCo
Geode Capital Management LLC Boosts Stake in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Defense World
INOVIO to Present at Upcoming Scientific and Investor Conferences - The Bradford Era
INOVIO to Present at Upcoming Scientific and Investor Conferences | INO Stock News - GuruFocus
XTX Topco Ltd Acquires New Position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Defense World
INOVIO Reveals Breakthrough: DNA Therapy INO-3107 Cuts RRP Surgeries by 81%First Long-Term Data - Stock Titan
INOVIO Q1 2025 Earnings: DNA Medicine Leader to Reveal Latest Financial Performance May 13 - Stock Titan
Bank of Montreal Can Makes New $43,000 Investment in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Defense World
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
Inovio Pharmaceuticals Inc. stock rises Thursday, still underperforms market - MarketWatch
Human Papillomavirus Market Set for Breakthrough Expansion - openPR.com
Inovio Pharmaceuticals Inc. stock rises Wednesday, still underperforms market - MarketWatch
Bet on These 5 Top-Ranked Stocks With Rising P/E - Nasdaq
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Inovio Pharmaceuticals (NASDAQ:INO) Raised to “Hold” at StockNews.com - Defense World
Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial - ADVFN
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Inovio Pharmaceuticals Inc. stock rises Friday, still underperforms market - MarketWatch
INOVIO to Highlight Breakthrough Immunotherapy Data at AACR Conference - MSN
INOVIO to Showcase Breakthrough Data on INO-3107 at Major Industry Conferences - MyChesCo
Inovio (INO) Upgraded to Buy: Here's What You Should Know - MSN
INOVIO Reports Inducement Grant Under Inducement Plan - MarketScreener
Next-generation Covid-19 vaccines currently being tested - Yahoo Finance
INOVIO to Present at Upcoming Scientific Conferences | INO Stock News - GuruFocus
INOVIO to Present at Upcoming Scientific Conferences - Longview News-Journal
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Inovio Pharmaceuticals Inc (INO) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):